Correlation Between Endonovo Therapeutics and Cingulate

Can any of the company-specific risk be diversified away by investing in both Endonovo Therapeutics and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Endonovo Therapeutics and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Endonovo Therapeutics and Cingulate, you can compare the effects of market volatilities on Endonovo Therapeutics and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Endonovo Therapeutics with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Endonovo Therapeutics and Cingulate.

Diversification Opportunities for Endonovo Therapeutics and Cingulate

0.38

Correlation Coefficient

Endonovo Therapeutics  Cingulate

Weak diversification

The 3 months correlation between Endonovo and Cingulate is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Endonovo Therapeutics and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Endonovo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Endonovo Therapeutics are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Endonovo Therapeutics i.e., Endonovo Therapeutics and Cingulate go up and down completely randomly.

Pair Corralation between Endonovo Therapeutics and Cingulate

Given the investment horizon of 90 days Endonovo Therapeutics is expected to generate 13.4 times more return on investment than Cingulate. However, Endonovo Therapeutics is 13.4 times more volatile than Cingulate. It trades about 0.16 of its potential returns per unit of risk. Cingulate is currently generating about 0.05 per unit of risk. If you would invest  0.02  in Endonovo Therapeutics on March 7, 2025 and sell it today you would lose (0.01) from holding Endonovo Therapeutics or give up 50.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

Endonovo Therapeutics  vs.  Cingulate

Endonovo Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Endonovo Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental indicators, Endonovo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Cingulate

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Cingulate reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Endonovo Therapeutics and Cingulate

The main advantage of trading using opposite Endonovo Therapeutics and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Endonovo Therapeutics position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.

The idea behind Endonovo Therapeutics and Cingulate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.